Name Chapter 6: Adaptive Immunity I. Characteristics of Adaptive

Total Page:16

File Type:pdf, Size:1020Kb

Load more

PATHOPHYSIOLOGY Name Chapter 6: Adaptive Immunity I. Characteristics of Adaptive Immunity A. General Characteristics Third line of defense (after surface barriers and inflammation) Compared to inflammation it is: o Slower, more specific, and longer lasting. Acquired after contact with antigens (so also called acquired immunity) Adaptive response usually initiated by cells of innate system, primarily phagocytes. Recognizes specific antigens. Provides memory to fight pathogens when they are encountered again. B. Components 1. Antigen presenting cells (APCs, macrophages or other phagocytes) process invading pathogens. o Present portions of engulfed pathogens to lymphocytes in peripheral lymphoid tissue. 2. Lymphocytes mediate adaptive immune response (primary cells responsible) o B lymphocytes (B cells) - responsible for humoral immunity. o T lymphocytes (T cells) - responsible for cell-mediated immunity. C. Humoral and Cell-Mediated Immunity 1. Humoral immunity - mediated by circulating antibodies made by activated B cells (plasma cells). 2. Cell-mediated immunity - T cells kill targets directly or stimulate the activity of other leukocytes. D. Active and Passive Immunity 1. Active immunity – an immune response originated in the host after exposure to an antigen. o Natural exposure or through immunization 2. Passive immunity – pre-formed antibodies or T cells are passed to the host from a donor. o Mother to child across placenta or through milk, or injection of antiserum containing immune globulins. ACTIVITY 1: Match the type of immunity to its description or characteristic. a. Innate immunity c. Humoral immunity e. Active immunity b. Adaptive immunity d. Cell-mediated immunity f. Passive immunity 1. Immunity conferred on a host by transfer of antibodies from a donor. 2. Involves direct attack upon pathogens by T cells. 3. Includes the inflammatory response and other nonspecific protective mechanisms. 4. Immune mechanisms that are acquired after contact with a specific antigen. 5. Immune response that specifically involves antibodies and B cells. 6. The type of immunity produced by vaccinations. 2 E. Antigens 1. Antigens - molecules that react with components of the immune response, such as antibodies and receptors on B and T cells. o Most antigens then induce an immune response resulting in production of antibodies or activated T cells (thus they are also immunogens). 2. Antigenic-determinant (or epitope) - the precise chemical structure with which an antibody or a B or T cell receptor reacts. 3. Self-antigens - antigens on an individual's own cells or tissues (endogenous antigens). o The individual's immune system does not normally recognize self-antigens as immunogenic, a condition known as tolerance. o Autoimmunity – the immune system attacks the body’s own tissues as if they were foreign. II. Humoral Immune Response The humoral immune response is provided by molecules (antibodies) produced by B cells. A. Antibodies (Immunoglobulins) 1. Serum glycoproteins produced by mature B cells in response to an antigenic challenge. 2. Classification - by chemical structure and biologic activity. a. IgG – most abundant, provides most protection (especially after initial exposure), found in near adult levels even in blood of newborn. b. IgA – found in body secretions and transferred from mother to infant in milk; acts as antigen receptor in mucosal membranes (prevents them entering body). c. IgM – first type produced after exposure; made prenatally so responds to infections in womb. d. IgD – acts as antigen receptor on the surface of early B cells. e. IgE – mediates allergic responses (including anaphylaxis) and protects against parasites. 3. Molecular structure – antibodies are Y-shaped molecules consisting of four polypeptide chains. a. Antigen-binding fragments (Fab) (2) – the two arms of the Y; the end of each has the site that recognizes and binds to antigen. o Complementary-determining regions (CDRs) – highly variable regions that determine the specificity of a given antibody (what it binds to). b. Crystalline fragment (Fc) (1) – the base of the Y, responsible for most of the biological properties of antibodies; this portion interacts with inflammatory cells. ACTIVITY 2: On the diagram of IgG, label the following: a. Fab portion b. Fc portion c. CDR regions d. Put a star (*) at the points where the antibody interacts with antigen. 3 B. Function of antibodies To protect against infection, either directly or indirectly. 1. Direct effects – can act against infectious agent or their toxins by: Neutralization – prevents binding to receptors and entry into cells Agglutination – causes clumping of antigens with antibody, forming immune complexes Precipitation – takes a soluble antigen out of solution 2. Indirect effects - activation of inflammation through the Fc portion of the molecule. Causes: Opsonization – coats particle to increase phagocytosis Complement activation - kills the infectious agent through MAC formation. 3. Internal - antibodies of the systemic immune system function internally, in the bloodstream and tissues. 4. External - antibodies of the secretory, or mucosal, immune system (primarily secretory IgA) function in the secretions of mucous membranes. C. Monoclonal antibodies 1. Produced in the laboratory from one B cell that has been cloned, thus all the antibody is of the same class, specificity, and function. 2. Used for sensitive laboratory tests (for example, pregnancy tests) and cancer therapies. III. Cell-Mediated Immune Response Accomplished by T cells to protect against viruses, tumors, and pathogens resistant to phagocytosis. There are several types of mature T cells: cytotoxic T cells (Tc), regulatory T cells including T-helper (Th) and T-suppressor (Ts) cells, and memory cells. A. T Cell Recognition of Target 1. Process of Recognition T cells have antigen specific receptors (T cell receptor or TCR) that must “see” antigen. This requires presentation of antigen by molecules of the major histocompatibility complex. 2. Major Histocompatibility Complex (MHC) Molecules These are antigens on the surface of all body cells, except RBCs. Used to distinguish “self” from “nonself” MHC Class I – used to present fragments of antigen to most immune cells; present on most cells. MHC Class II – required for presentation of antigen to T-helper cells (Th cells); on APCs and B cells. 3. Superantigens (SAGs) Molecules that bind to the variable portion of the TCR and the MHC class II molecules outside of their antigen-presentation sites. Activates a large population of T-lymphocytes regardless of antigen specificity. SAGs induce an excessive production of cytokines. o Causes fever, low blood pressure, and potentially shock. Examples: Toxins produced by Staphylococcus aureus (toxic shock syndrome) and Streptococcus pyogenes (food poisoning). 4 B. T Lymphocyte Functions 1. Killing abnormal cells a. Cytotoxic T lymphocytes (Tc cells) - kill cells infected with viruses or cancer cells. Kill targets by producing toxins and stimulating the cells to undergo apoptosis. Tc cells have CD8 molecules that bind to MHC class I on the target (so called CD8 cells). Activated by Th1 cells (T-helper cells, type 1). b. Natural Killer (NK) Cells – similar to Tc cells, but they are less specific and can attack a wide range of cancerous or virus-infected cells. Antibody-dependent cellular cytotoxicity (ADCC) – allows NK cells to target any cells that have IgG bound to their surface, so they can coordinate with other immune responses. 2. Macrophage activation – during chronic inflammation, T cells release cytokines to activate macrophages. 3. Regulation of humoral and cell-mediated immunity – both require activity of T-helper cells. Th cells have CD4 molecules that bind to MHC Class II antigens on macrophages and B cells. The AIDS virus specifically attacks CD4 cells, including Th cells. IV. Phases of Immune Response A. Generation of clonal diversity Occurs before birth in the thymus (T cells) and bone marrow (B cells). The body produces millions of different T and B cells that each have receptors to recognize one specific antigen. Thus there should be a B or T cell that can recognize any antigen the body encounters. These are released into body and migrate to other lymphoid organs to await exposure to antigen. B. Induction of the Immune Response Also referred to as clonal selection Antigen presenting cells interact with B and T cells that recognize the antigen carried by an APC. This activates the lymphocyte, causing it to proliferate. B cells become plasma cells that secrete large amounts of antibody against the antigen. T cells become cytotoxic T cells capable of direct attack against cells carrying antigen. T-helper cells are needed to facilitate B and T cell activation. C. Primary Response Occurs the first time the body is exposed to a particular antigen. A latent period of 5-7 days occurs during which B cell clonal selection occurs. Activated by Th2 cells (T-helper cells, type 2). IgM is detected in blood first, followed by IgG. Memory B cells form. 5 D. Secondary Response Occurs each successive time that the body encounters this antigen. Memory B cells are rapidly activated and produce large amounts of IgG very quickly. ACTIVITY 3: Match the lymphocyte activity with the type of cells involved. a. T cells b. B cells c. Both T and B cells 1. Undergo clonal selection after activation. 2. Produce cytokines. 3. Form helper and suppressor cells. 4. Produce antibodies. 5. Directly attack infected
Recommended publications
  • THE IMMUNE SYSTEM Blood Cells Cells of the Immune System

    THE IMMUNE SYSTEM Blood Cells Cells of the Immune System

    THE IMMUNE SYSTEM Blood Cells Cells of the Immune System White Blood Cells • Phagocytes - Neutrophils - Macrophages • Lymphocytes Phagocytes • Produced throughout life by the bone marrow. • Scavengers – remove dead cells and microorganisms. Neutrophils • 60% of WBCs • ‘Patrol tissues’ as they squeeze out of the capillaries. • Large numbers are released during infections • Short lived – die after digesting bacteria • Dead neutrophils make up a large proportion of puss. Macrophages • Larger than neutrophils. • Found in the organs, not the blood. • Made in bone marrow as monocytes, called macrophages once they reach organs. • Long lived • Initiate immune responses as they display antigens from the pathogens to the lymphocytes. Macrophages Phagocytosis Phagocytosis • If cells are under attack they release histamine. • Histamine plus chemicals from pathogens mean neutrophils are attracted to the site of attack. • Pathogens are attached to antibodies and neutrophils have antibody receptors. • Enodcytosis of neutrophil membrane phagocytic vacuole. • Lysosomes attach to phagocytic vacuole pathogen digested by proteases Lymphocytes • Produce antibodies • B-cells mature in bone marrow then concentrate in lymph nodes and spleen • T-cells mature in thymus • B and T cells mature then circulate in the blood and lymph • Circulation ensures they come into contact with pathogens and each other B -Lymphocytes • There are c.10 million different B- lymphocytes, each of which make a different antibody. • The huge variety is caused by genes coding for abs changing slightly during development. • There are a small group of clones of each type of B-lymphocyte B -Lymphocytes • At the clone stage antibodies do not leave the B- cells. • The abs are embedded in the plasma membrane of the cell and are called antibody receptors.
  • LECTURE 05 Acquired Immunity and Clonal Selection

    LECTURE 05 Acquired Immunity and Clonal Selection

    LECTURE: 05 Title: ACQUIRED "ADAPTIVE" IMMUNITY & CLONAL SELECTION THEROY LEARNING OBJECTIVES: The student should be able to: • Recognize that, acquired or adaptive immunity is a specific immunity. • Explain the mechanism of development of the specific immunity. • Enumerate the components of the specific immunity such as A. Primary immune response. B. Secondary immune response • Explain the different phases that are included in the primary and secondary immune responses such as: A. The induction phase. B. Exponential phase. C. Steady phase. D. Decline phase. • Compare between the phases of the primary and secondary immune responses. • Determine the type of the immunoglobulins involved in each phase. • Determine which immunoglobulin is induced first and, that last longer. • Enumerate the characteristics of the specific immunity such as: A. The ability to distinguish self from non-self. B. Specificity. C. Immunological memory. • Explain naturally and artificially acquired immunity (passive, and active). • Explain the two interrelated and independent mechanisms of the specific immune response such as : A. Humoral immunity. B. Cell-mediated (cellular) immunity. • Recognize that, the specific immunity is not always protective, for example; sometimes it causes allergies (hay fever), or it may be directed against one of the body’s own constituents, resulting in autoimmunity (thyroditis). LECTURE REFRENCE: 1. TEXTBOOK: ROITT, BROSTOFF, MALE IMMUNOLOGY. 6th edition. Chapter 2. pp. 15-31 2. TEXTBOOK: ABUL K. ABBAS. ANDREW H. LICHTMAN. CELLULAR AND MOLECULAR IMMUNOLOGY. 5TH EDITION. Chapter 1. pg 3-12. 1 ACQUIRED (SPECIFIC) IMMUNITY INTRODUCTION Adaptive immunity is created after an interaction of lymphocytes with particular foreign substances which are recognized specifically by those lymphocytes.
  • The Relationship Between Maternal Postpartum Psychological State and Breast Milk Secretory Immunoglobulin a Level

    The Relationship Between Maternal Postpartum Psychological State and Breast Milk Secretory Immunoglobulin a Level

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Tsukuba Repository The Relationship Between Maternal Postpartum Psychological State and Breast Milk Secretory Immunoglobulin A Level 著者 Kawano Atsuko, Emori Yoko journal or Journal of the American Psychiatric Nurses publication title Association volume 21 number 1 page range 23-30 year 2015-01 権利 Authors URL http://hdl.handle.net/2241/00124572 doi: 10.1177/1078390314566882 The relationship between maternal postpartum psychological state and breast milk secretory immunoglobulin A level. Kawano A, Emori Y. J Am Psychiatr Nurses Assoc. 2015 Jan-Feb;21(1):23-30. doi: 10.1177/1078390314566882. Epub 2015 Jan 14. PMID:25589451 Abstract BACKGROUND: Maternal psychological state may influence the passive transfer of immune factors (e.g., immunoglobulin) via the mother’s breast milk. OBJECTIVE: The aim of this study was to determine whether a correlation exists between mothers’ postpartum psychological state and their breast milk secretory immunoglobulin A (SIgA) levels. STUDY DESIGN: Eighty-one mothers who delivered at an urban general hospital were included in our analysis. Two weeks after delivery, we measured their breast milk SIgA levels and simultaneously documented their psychological state using the Profile of Mood States (POMS), General Health Questionnaire (GHQ), and State-Trait Anxiety Inventory (STAI) scales. RESULTS: Breast milk SIgA levels were negatively correlated with negative POMS states (tension-anxiety, depression-dejection, anger-hostility, fatigue, and confusion). A negative correlation was also observed between SIgA levels and GHQ mental health (r = −.625, P = .000), and a similar negative correlation was observed with STAI trait and state anxieties.
  • Vaccine Immunology Claire-Anne Siegrist

    Vaccine Immunology Claire-Anne Siegrist

    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
  • Humoral Immunity and Complement Humoral Immunity B Cell Antigens

    Humoral Immunity and Complement Humoral Immunity B Cell Antigens

    Humoral Immunity Humoral Immunity and Complement Transfer of non-cell components of blood-- Robert Beatty antibodies, complement MCB150 Humoral immunity = antibody mediated B Cell Activation of T-dependent antigens B cell Antigens T cell dependent B cell antigens T cell independent Majority of antigens. Do not require thymus. Most protein antigens. No memory. T cell help required for B cell activation and antibody production. T-cell dependent antigens T-cell independent antigens 1 B Cell Activation T-dependent antigens Location of B Cell Activation Antigen activated B cells remain in T cell zones of LN. Linked Recognition Maximize contact of Need T cell epitope along with B cell epitope to B cells with T cells. get antibody response. B cells get help from T cells, help = CD40Ligand and IL-4. Clonal proliferation In Follicles Isotype Switching Affinity maturation Somatic hypermutation 2 T cell Independent Antigens B cell mitogens (e.g. LPS) B-1 cells At low levels normal immune response to LPS Activated by repeating CHO epitopes that provide crosslinking At high levels LPS can cause non-antigen specific to induce antigen uptake and activation. activation of B cells. Mitogen effect Antigen specific immune response Lower affinity, lower numbers, no memory. Primarily IgM. Antibody Effector Functions Opsonization Neutralization Antibody Effector Functions Enhancement of phagocytosis Neutralizing abs block active site for adherence, entry into host cell, or active site of toxin Neutralizing antibodies are usually high affinity and primarily IgG. 3 Antibody-dependent cell-mediated Complement Activation cytotoxicity (ADCC) Antibody Effector Functions Antibody Effector Functions Antibody binds to pathogen or infected target cell.
  • Cellular and Humoral Components of Monocyte and Neutrophil Chen1otaxis in Cord Blood

    Cellular and Humoral Components of Monocyte and Neutrophil Chen1otaxis in Cord Blood

    Pediat. Res. 11: 677-()1\0 (1977) Chemotaxis neutrophil complement newborn monocytes phagocytes Cellular and Humoral Components of Monocyte and Neutrophil Chen1otaxis in Cord Blood SAYITA G . PAHWA.""'' RAJENDRA PAHWA. ELENA GRII\IES. AND E LIZA13 ETII SI\IITII\VICK Departlllt'lll of Pediatrics aml/nmrwwlogy, Memorial Sloa/1-1\ellcrillg Ca11ca Centa, Nell' York, New York , USA Summary experiment, blood from a healthy adult was tested simultane­ ously. 1\lonoqte and polymorphonuclear neutrophil (J>I\IN) chemo­ taxis was studied in cord blood from healthv term infants. 1\Jono­ ISOLATION OF CELLS c;yte chemotaxis was normal to increased ( 115-126%) whereas PI\IN chemotaxis was decreased (79%) in comparison with that Mononuclear leukocytes were isolated by density gradient of healthy adult l'ontrol subjects. Generation of chemotactic centrifugation on a sodium mctrizoatc-Ficoll solution (Lympho­ factors from cord sera was impaired, being 55% of that gener­ prep. Nyegard and Co., Oslo) (5). The cells were washed three ated by J)(Wied normal human serum (I'NIIS). Cord serum was times and resuspended in RPI\11 (Gibco) supplemented with less inhibitory than pooled adult human serum fur adult mono­ penicillin 50 units, streptomycin 50 Jlg . and glutamine 2 ml\1/ml. qtes when the cells were suspended in HI % serum and tested for As simultaneous analysis of monocytcs by myelopcroxidasc stain chemotaxis. No inhibition of chemotactic factors by either cord and Wright stain were in close agreement. the percentage of or adult sera was observed. The dissociation of chemotactic monocytcs was routinely determined by a myelopcroxidasc stain response of the two diiTerent phagocytic cells may represent a ( 13 ); Wright stain was done to exclude contamination by gra nu­ protecth·e mechanism whereby one cell can compensate for a locytes.
  • Current Trends in Research on Human Milk Exchange for Infant Feeding

    Current Trends in Research on Human Milk Exchange for Infant Feeding

    Current trends in research on human milk exchange for infant feeding By: Aunchalee E. L. Palmquist, Maryanne T. Perrin, Diana Cassar-Uhl, Karleen D. Gribble, Angela B. Bond, and Tanya Cassidy Palmquist AEL, Perrin MT, Cassar-Uhl D, Gribble KD, Bond AB, Cassidy T. Current Trends in Research on Human Milk Exchange for Infant Feeding. Journal of Human Lactation. 2019;35(3):453-477. doi:10.1177/0890334419850820 Made available courtesy of SAGE publications: https://doi.org/10.1177/0890334419850820 ***© 2019 The Authors. Reprinted with permission. No further reproduction is authorized without written permission from SAGE. This version of the document is not the version of record. *** Abstract: Breastfeeding is critical for the healthy growth and development of infants. A diverse range of infant-feeding methods are used around the world today. Many methods involve feeding infants with expressed human milk obtained through human milk exchange. Human milk exchange includes human milk banking, human milk sharing, and markets in which human milk may be purchased or sold by individuals or commercial entities. In this review, we examine peer- reviewed scholarly literature pertaining to human milk exchange in the social sciences and basic human milk sciences. We also examine current position and policy statements for human milk sharing. Our review highlights areas in need of future research. This review is a valuable resource for healthcare professionals and others who provide evidence-based care to families about infant feeding. Keywords: human milk | human milk expression | infant-feeding patterns | lactation | milk banking | breastfeeding Article: Key Messages • Breastfeeding is critical for the healthy growth and development of infants, but it is not always possible or desired.
  • Greenbook Chapter 1

    Greenbook Chapter 1

    Chapter 1: Immunity and how vaccines work December 2018 1 Immunity and how vaccines work vaccines work Introduction Immunity and how Immunity is the ability of the human body to protect itself from infectious disease. The defence mechanisms of the body are complex and include innate (non-specific, non-adaptive) mechanisms and acquired (specific, adaptive) systems. Innate or non-specific immunity is present from birth and includes physical barriers (e.g. intact skin and mucous membranes), chemical barriers (e.g. gastric acid, digestive enzymes and bacteriostatic fatty acids of the skin), phagocytic cells and the complement system. Acquired immunity is generally specific to a single organism or to a group of closely related organisms. There are two basic mechanisms for acquiring immunity – active and passive. Active immunity Active immunity is protection that is produced by an individual’s own immune system and is usually long-lasting. Such immunity generally involves cellular responses, serum antibodies or a combination acting against one or more antigens on the infecting organism. Active immunity can be acquired by natural disease or by vaccination. Vaccines generally provide immunity similar to that provided by the natural infection, but without the risk from the disease or its complications. Active immunity can be divided into antibody- mediated and cell-mediated components. Antibody-mediated immunity Antibody-mediated responses are produced by B lymphocytes (or B cells), and their direct descendants, known as plasma cells. When a B cell encounters an antigen that it recognises, the B cell is stimulated to proliferate and produce large numbers of lymphocytes secreting an antibody to this antigen.
  • I M M U N O L O G Y Core Notes

    I M M U N O L O G Y Core Notes

    II MM MM UU NN OO LL OO GG YY CCOORREE NNOOTTEESS MEDICAL IMMUNOLOGY 544 FALL 2011 Dr. George A. Gutman SCHOOL OF MEDICINE UNIVERSITY OF CALIFORNIA, IRVINE (Copyright) 2011 Regents of the University of California TABLE OF CONTENTS CHAPTER 1 INTRODUCTION...................................................................................... 3 CHAPTER 2 ANTIGEN/ANTIBODY INTERACTIONS ..............................................9 CHAPTER 3 ANTIBODY STRUCTURE I..................................................................17 CHAPTER 4 ANTIBODY STRUCTURE II.................................................................23 CHAPTER 5 COMPLEMENT...................................................................................... 33 CHAPTER 6 ANTIBODY GENETICS, ISOTYPES, ALLOTYPES, IDIOTYPES.....45 CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION..................................................................53 CHAPTER 8 GENETIC BASIS OF ANTIBODY DIVERSITY...................................61 CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS ...............................................69 CHAPTER 10 BLOOD GROUPS: ABO AND Rh .........................................................77 CHAPTER 11 CELL-MEDIATED IMMUNITY AND MHC ........................................83 CHAPTER 12 CELL INTERACTIONS IN CELL MEDIATED IMMUNITY ..............91 CHAPTER 13 T-CELL/B-CELL COOPERATION IN HUMORAL IMMUNITY......105 CHAPTER 14 CELL SURFACE MARKERS OF T-CELLS, B-CELLS AND MACROPHAGES...............................................................111
  • Vaccines Why Use Passive Immunity?

    Vaccines Why Use Passive Immunity?

    Vaccines n Active vs Passive Immunization n Active is longer acting and makes memory and effector cells n Passive is shorter acting, no memory and no effector cells n Both can be obtained through natural processes: n Getting antibodies from mother n Directly getting the disease n Or by unnatural processes n Being given pre-formed antibodies (gamma globulin shot) n Altered (attenuated) vaccines, toxoids n Immunity elicited in one animal can be transferred to another animal by injecting the recipient animal with serum from the immune animal n Passive immunization= pre-formed antibodies given from one individual to another (across placenta, gamma globulin injection) Why use passive immunity? n Deficiency in synthesis of Ig because of congenital or acquired defects n When a susceptible person is likely to be exposed to disease n When time does not permit adequate protection through active immunization n When a disease is already present and Ig may help to ameliorate or help to suppress the effects of toxin (tetanus, diphtheria or botulism) n Passive Immunity- n Natural maternal Ab & Immune globulin & Antitoxin n Active Immunity- n Natural Infection n Vaccines (attenuated & inactivated organisms & purified microbial proteins, cloned microbial antigens & toxoids) 1 n Tetanus- horse serum (horses do NOT get tetanus and can be injected with tetanus toxin) n Horse produces antibodies to toxin and when injected into person they act to neutralize toxin to prevent binding (serum sickness to horse albumin possible) n People can be given a toxoid (altered
  • B Cell Activation and Humoral Immunity

    B Cell Activation and Humoral Immunity

    B cell activation and Humoral Immunity Humoral immunity is mediated by secreted antibodies and its physiological function is defense against extracellular microbes (including viruses) and microbial exotoxins. Humoral immunity can be transferred to other individuals by the transfer of serum (antibodies). Defect in humoral immunity leads to enhanced infections by bacteria and fungi. Antibodies also participate in autoimmune disorders and hypersensitivity. When an antigen with multiple epitopes gains entry into the body, different clones of B cells recognize and produce antibodies against different epitopes, thus the natural response is said to by polyclonal. However, by using hybridoma technology it is possible to develop a clone of B cells directed against a single epitope, and produce monoclonal antibodies. Antibodies are produced by plasma cells in the secondary lymphoid organs, but antibodies can perform their effector functions at any site in the body. Once the antibodies enter the circulation or mucosa, they can easily reach sites of infection. Circulating antibodies can recognize antigen present in blood or can pass through the endothelium into tissue spaces and render their effector functions. The first exposure to a microbe or an antigen, either by infection or by vaccination, leads to the activation of naive B lymphocytes. These B cells differentiate into antibody-producing plasma cells and memory cells. Some of the antibody producing cells migrate to the bone marrow and live in this site for several years, where they continue to produce antibodies even when antigen has been eliminated. It is estimated that over half the IgG found in serum of normal individuals is derived from these long-lived antibody producing cells, which were induced by exposure to various antigens throughout the life of the individual.
  • 1. Introduction to Immunology Professor Charles Bangham (C.Bangham@Imperial.Ac.Uk)

    1. Introduction to Immunology Professor Charles Bangham ([email protected])

    MCD Immunology Alexandra Burke-Smith 1. Introduction to Immunology Professor Charles Bangham ([email protected]) 1. Explain the importance of immunology for human health. The immune system What happens when it goes wrong? persistent or fatal infections allergy autoimmune disease transplant rejection What is it for? To identify and eliminate harmful “non-self” microorganisms and harmful substances such as toxins, by distinguishing ‘self’ from ‘non-self’ proteins or by identifying ‘danger’ signals (e.g. from inflammation) The immune system has to strike a balance between clearing the pathogen and causing accidental damage to the host (immunopathology). Basic Principles The innate immune system works rapidly (within minutes) and has broad specificity The adaptive immune system takes longer (days) and has exisite specificity Generation Times and Evolution Bacteria- minutes Viruses- hours Host- years The pathogen replicates and hence evolves millions of times faster than the host, therefore the host relies on a flexible and rapid immune response Out most polymorphic (variable) genes, such as HLA and KIR, are those that control the immune system, and these have been selected for by infectious diseases 2. Outline the basic principles of immune responses and the timescales in which they occur. IFN: Interferon (innate immunity) NK: Natural Killer cells (innate immunity) CTL: Cytotoxic T lymphocytes (acquired immunity) 1 MCD Immunology Alexandra Burke-Smith Innate Immunity Acquired immunity Depends of pre-formed cells and molecules Depends on clonal selection, i.e. growth of T/B cells, release of antibodies selected for antigen specifity Fast (starts in mins/hrs) Slow (starts in days) Limited specifity- pathogen associated, i.e.